We are a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer. We apply our ProTide technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines.Learn more
We harness the power of phosphoramidate chemistry to develop next-generation chemotherapeutics designed to overcome the key cancer resistance mechanisms of existing nucleoside analogs.Discover More
To Transform Chemotherapy and Pioneer a New Era in Oncology
Biology Week 2020
NuCana features on 'Biology for the Future' - a news and current affairs style series by ITN Productions and the Royal Society of Biology (RSB).